Open Access
J Extra Corpor Technol
Volume 52, Number 2, June 2020
Page(s) 103 - 111
Published online 15 June 2020
  1. Ferraris VA, Brown JR, Despotis GJ, et al. Update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944–82. [CrossRef] [PubMed] [Google Scholar]
  2. Scott BH, Seifert FC, Grimson R Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth. 2008;11:15–9. [CrossRef] [PubMed] [Google Scholar]
  3. Christensen MC, Krapf S, Kempel A, et al. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg. 2009;138:687–93. [CrossRef] [PubMed] [Google Scholar]
  4. Rogers MA, Blumberg N, Saint S, et al. Hospital variation in transfusion and infection after cardiac surgery: A cohort study. BMC Med. 2009;7:37. [CrossRef] [PubMed] [Google Scholar]
  5. LaPar DJ, Crosby IK, Ailawadi G, et al. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg. 2013;145:796–803; discussion 803-4. [CrossRef] [PubMed] [Google Scholar]
  6. Banbury MK, Brizzio ME, Rajeswaran J, et al. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg. 2006;202:131–8. [CrossRef] [PubMed] [Google Scholar]
  7. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81:1650–7. [CrossRef] [PubMed] [Google Scholar]
  8. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608–16. [CrossRef] [PubMed] [Google Scholar]
  9. Bjursten H, Dardashti A, Ederoth P, et al. Increased long-term mortality with plasma transfusion after coronary artery bypass surgery. Intensive Care Med. 2013;39:437–44. [CrossRef] [PubMed] [Google Scholar]
  10. Bhaskar B, Dulhunty J, Mullany DV, et al. Impact of blood product transfusion on short and long-term survival after cardiac surgery: More evidence. Ann Thorac Surg. 2012;94:460–7. [CrossRef] [PubMed] [Google Scholar]
  11. Chen A, Teruya J Global hemostasis testing thromboelastography: Old technology, new applications. Clin Lab Med. 2009;29:391–407. [CrossRef] [PubMed] [Google Scholar]
  12. Aoki K, Sugimoto A, Nagasawa A, et al. Optimization of thromboelastography-guided platelet transfusion in cardiovascular surgery. Gen Thorac Cardiovasc Surg. 2012;60:411–6. [CrossRef] [PubMed] [Google Scholar]
  13. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg. 2009;24:404–10. [CrossRef] [PubMed] [Google Scholar]
  14. Anderson L, Quasim I, Soutar R, et al. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med. 2006;16:31–9. [CrossRef] [PubMed] [Google Scholar]
  15. Bolliger D, Tanaka KA Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev. 2013;27:213–20. [CrossRef] [PubMed] [Google Scholar]
  16. Girdauskas E, Kempfert J, Kuntze T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial. J Thorac Cardiovasc Surg. 2010;140:1117–24.e2. [CrossRef] [PubMed] [Google Scholar]
  17. Shore-Lesserson L, Manspeizer HE, DePerio M, et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg. 1999;88:312–9. [CrossRef] [PubMed] [Google Scholar]
  18. Weber CF, Gorlinger K, Meininger D, et al. Point-of-care testing: A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology. 2012;117:531–47. [CrossRef] [PubMed] [Google Scholar]
  19. Association of Surgical Technologists. Guidelines for Best Practices in Intraoperative Cell Salvage. 2018 Littleton, CO: Association of Surgical Technologists. [Google Scholar]
  20. Fleming K, Redfern RE, March RL, et al. TEG-directed transfusion in complex cardiac surgery: Impact on blood product usage. J Extra Corpor Technol. 2017;49:283–90. [PubMed] [Google Scholar]
  21. Shander A, Hofmann A, Gombotz H, et al. Estimating the cost of blood: Past, present, and future directions. Best Pract Res Clin Anaesthesiol. 2007;21:271–89. [CrossRef] [PubMed] [Google Scholar]
  22. Federal Reserve Bank of St Louis (FRED). 2018 Available at: Accessed May 12, 2018. [Google Scholar]
  23. Spalding GJ, Hartrumpf M, Sierig T, et al. Cost rreduction of perioperative coagulation management in cardiac surgery: Value of “bedside” thrombelastography (ROTEM). Eur J Cardio Thorac Surg. 2007;31:1052–7. [CrossRef] [Google Scholar]
  24. Fassl J, Matt P, Eckstein F, et al. Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: Effect of thromboelastometry-guided transfusion management. J Cardiothorac Vasc Anesth. 2013;27:1181–8. [CrossRef] [PubMed] [Google Scholar]
  25. Spiess BD, Gillies BS, Chandler W, et al. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth. 1995;9:168–73. [CrossRef] [PubMed] [Google Scholar]
  26. Royston D, von Kier S Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth. 2001;86:575–8. [CrossRef] [PubMed] [Google Scholar]
  27. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of A Simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773–81; discussion 5A–6A. [CrossRef] [PubMed] [Google Scholar]
  28. Mehaffey JH, Schubert SA, Gelvin MG, et al. A new intraoperative protocol for reducing perioperative transfusions in cardiac surgery. Ann Thorac Surg. 2017;104:176–81. [CrossRef] [PubMed] [Google Scholar]
  29. Gorlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study. Anesthesiology. 2011;115:1179–91. [CrossRef] [PubMed] [Google Scholar]
  30. Galeone A, Rotunno C, Guida P, et al. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27:853–8. [CrossRef] [PubMed] [Google Scholar]
  31. Hanke AA, Herold U, Dirkmann D, et al. Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requirements, adverse events, and costs in acute type A aortic dissection: A pilot study. Transfus Med Hemother. 2012;39:121–8. [CrossRef] [PubMed] [Google Scholar]
  32. Westbrook AJ, Olsen J, Bailey M, et al. Protocol based on Thromboelastograph (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: A pilot study. Heart Lung Circ. 2009;18:277–88. [CrossRef] [PubMed] [Google Scholar]
  33. Karkouti K, Callum J, Wijeysundera DN, et al. Point-of-Care hemostatic testing in cardiac surgery: A stepped-wedge clustered randomized controlled trial. Circulation. 2016;134:1152–62. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.